Physician profile
Daniel John Yee
NPI 1619414430
$702.96
in general payments reported to CMS, 2019-2025
16 companies · $285 in 2025
The $285 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $157 · 2022: $116 · 2024: $146 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $430.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $137.53 | 2021 | |
| Intuitive Surgical, INC. | $116.00 | 2022 | |
| Novartis Pharmaceuticals Corporation | $54.68 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.22 | 2024-2025 | Fruzaqla |
| Abbvie INC. | $45.27 | 2024 | |
| Eisai INC. | $44.35 | 2024-2025 | |
| Array Biopharma INC | $33.41 | 2025 | Lorbrena, Braftovi, Mektovi |
| Ipsen Biopharmaceuticals, INC | $32.64 | 2025 | Onivyde |
| Adc Therapeutics America, INC. | $31.82 | 2025 | |
| Recordati_rare_diseases_inc. | $27.56 | 2025 | Enjaymo |
| Astrazeneca Pharmaceuticals Lp | $24.28 | 2025 | Enhertu |
| Daiichi Sankyo INC. | $22.64 | 2025 | Enhertu |
| Tactile Systems Technology INC | $21.75 | 2025 | Flexitouch Plus, Nimbl |
| Pfizer INC. | $21.59 | 2025 | |
| Caris Mpi, INC. | $19.97 | 2025 | Mi Cancer Seek |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $19.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Yee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.